|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001792,
umls-concept:C0007131,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0205390,
umls-concept:C0246415,
umls-concept:C0332174,
umls-concept:C0796493,
umls-concept:C1516224,
umls-concept:C1831741
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2007-10-25
|
|
pubmed:abstractText |
The aim of this study was to compare the efficacy of single-agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2027-34
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17823908-Aged,
pubmed-meshheading:17823908-Aged, 80 and over,
pubmed-meshheading:17823908-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17823908-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17823908-Deoxycytidine,
pubmed-meshheading:17823908-Female,
pubmed-meshheading:17823908-Humans,
pubmed-meshheading:17823908-Kaplan-Meier Estimate,
pubmed-meshheading:17823908-Lung Neoplasms,
pubmed-meshheading:17823908-Male,
pubmed-meshheading:17823908-Middle Aged,
pubmed-meshheading:17823908-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.
|
|
pubmed:affiliation |
Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee, USA. jhainsworth@tnonc.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
